| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |